Breaking News Instant updates and real-time market news.

EXEL

Exelixis

$19.76

0.12 (0.61%)

06:03
05/13/19
05/13
06:03
05/13/19
06:03

Exelixis: Daiichi Sankyo launches MINNEBRO tablets in Japan

Exelixis announced its partner, Daiichi Sankyo Company, has launched MINNEBRO tablets as a treatment for patients with hypertension in Japan. With Daiichi Sankyo's first commercial sale of MINNEBRO, Exelixis will receive an associated $20M milestone payment from Daiichi Sankyo under the terms of the companies' collaboration agreement. Exelixis anticipates receiving the payment during the second quarter.

  • 22

    May

  • 31

    May

  • 05

    Jun

EXEL Exelixis
$19.76

0.12 (0.61%)

02/25/19
COWN
02/25/19
NO CHANGE
COWN
Exelixis coverage transferred with an Outperform at Cowen
Cowen analyst Yaron Werber assumed coverage of Exelixis with an Outperform rating and $29 price target. Werber noted that, "after strong growth, Cabometyx is facing intense competition that may pressure sales," but the analyst anticipates positive Phase 3 data from CHECKMATE-9ER in the second half of 2019 re-accelerating growth. Werber also believes that "recent strong bids for oncology companies may put Exelixis at play for takeout."
03/01/19
PIPR
03/01/19
NO CHANGE
Target $48
PIPR
Overweight
Exelixis price target raised to $48 from $26 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Exelixis to $48 after taking a closer look at the company's bottom-line including breaking out non-cash expenses. The analyst projects U.S. Cabometyx sales to grow from $600M in 2018, to $826M in 2019 and $1.07B in 2020. Factoring in a 22% projected tax rate, he forecasts GAAP net income of $300M, or 95c per diluted share, in 2019 to increase to $375M or $1.17, in 2020. Backing out non-cash stock comp and federal taxes, the analyst projects Non-GAAP net income to grow from $431M or $1.37 per diluted share in 2019 to $532M or $1.66 in 2020. Tenthoff reiterates an Overweight rating on Exelixis.
03/18/19
MSCO
03/18/19
UPGRADE
MSCO
Equal Weight
Exelixis upgraded to Equal Weight from Underweight at Morgan Stanley
03/18/19
MSCO
03/18/19
UPGRADE
Target $28
MSCO
Equal Weight
Morgan Stanley sees limited downside risk for Exelixis, upgrades to Equal Weight
As previously reported, Morgan Stanley analyst Jeffrey Hung upgraded Exelixis to Equal Weight from Underweight, citing his view there is limited downside risk for the stock ahead of the cabozantinib/nivolumab data from CheckMate 9ER later this year. Additionally, cabozantinib scripts are looking better in 2019 and Hung sees multiple ways this trend could continue, he tells investors. Hung raised his price target on Exelixis shares to $28 from $20.

TODAY'S FREE FLY STORIES

EL

Estee Lauder

$179.26

3.89 (2.22%)

06:45
08/19/19
08/19
06:45
08/19/19
06:45
Earnings
Estee Lauder reports Q4 EPS 64c, consensus 53c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

BAC

Bank of America

$27.04

0.79 (3.01%)

, C

Citi

$63.46

2.13 (3.47%)

06:45
08/19/19
08/19
06:45
08/19/19
06:45
Periodicals
Updated Volcker Rule expected this week, WSJ reports »

An updated Volcker Rule…

BAC

Bank of America

$27.04

0.79 (3.01%)

C

Citi

$63.46

2.13 (3.47%)

JPM

JPMorgan

$107.73

2.52 (2.40%)

USB

U.S. Bancorp

$52.25

0.99 (1.93%)

WFC

Wells Fargo

$44.40

1.01 (2.33%)

GS

Goldman Sachs

$199.39

3.2 (1.63%)

MS

Morgan Stanley

$39.94

0.85 (2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 06

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 27

    Oct

PCG

PG&E

$14.30

-0.08 (-0.56%)

06:44
08/19/19
08/19
06:44
08/19/19
06:44
Periodicals
PG&E holds on to sole rights to devise chapter 11 exit plan, WSJ reports »

A U.S. Bankruptcy Court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVGO

Livongo Health

$37.00

3.22 (9.53%)

06:42
08/19/19
08/19
06:42
08/19/19
06:42
Initiation
Livongo Health initiated  »

Livongo Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

ACM

Aecom

$32.97

0.53 (1.63%)

06:38
08/19/19
08/19
06:38
08/19/19
06:38
Upgrade
Aecom rating change  »

Aecom upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:37
08/19/19
08/19
06:37
08/19/19
06:37
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

NYNY

Empire Resorts

$8.35

-0.145 (-1.71%)

06:37
08/19/19
08/19
06:37
08/19/19
06:37
Hot Stocks
Empire Resorts to be acquired by Kien Huat, Genting Malaysia for $9.74 per share »

Empire Resorts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DECK

Deckers Brands

$134.33

1.39 (1.05%)

06:36
08/19/19
08/19
06:36
08/19/19
06:36
Upgrade
Deckers Brands rating change  »

Deckers Brands upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

  • 25

    Sep

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:35
08/19/19
08/19
06:35
08/19/19
06:35
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:33
08/19/19
08/19
06:33
08/19/19
06:33
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:32
08/19/19
08/19
06:32
08/19/19
06:32
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:31
08/19/19
08/19
06:31
08/19/19
06:31
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

WLL

Whiting Petroleum

$8.61

0.36 (4.36%)

06:30
08/19/19
08/19
06:30
08/19/19
06:30
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 08

    Oct

  • 09

    Oct

ARCC

Ares Capital

$18.63

0.27 (1.47%)

06:29
08/19/19
08/19
06:29
08/19/19
06:29
Upgrade
Ares Capital rating change  »

Ares Capital upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTVA

Corteva

$30.25

1.84 (6.48%)

06:26
08/19/19
08/19
06:26
08/19/19
06:26
Upgrade
Corteva rating change  »

Corteva upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$183.42

0.78 (0.43%)

, ACN

Accenture

$193.19

3.675 (1.94%)

06:25
08/19/19
08/19
06:25
08/19/19
06:25
Periodicals
Facebook content moderation firm sought counseling details, The Intercept says »

A Facebook (FB) content…

FB

Facebook

$183.42

0.78 (0.43%)

ACN

Accenture

$193.19

3.675 (1.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 26

    Sep

  • 27

    Oct

PROS

ProSight

$18.71

-0.5 (-2.60%)

06:23
08/19/19
08/19
06:23
08/19/19
06:23
Initiation
ProSight initiated  »

ProSight initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$206.44

4.71 (2.33%)

06:23
08/19/19
08/19
06:23
08/19/19
06:23
Periodicals
Apple CEO Cook has met Trump 'at least' 5 times in a year, BI reports »

Apple CEO Tim Cook has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POL

PolyOne

$31.01

0.73 (2.41%)

06:21
08/19/19
08/19
06:21
08/19/19
06:21
Earnings
PolyOne raises FY19 adj. EPS view to up 6%-8% from up 4%-6%, consensus $2.54 »

Guidance reflects the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

06:20
08/19/19
08/19
06:20
08/19/19
06:20
Periodicals
Amazon beats IRS appeal in U.S. tax dispute, Reuters reports »

Amazon on Friday defeated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ARMK

Aramark

$37.07

-0.07 (-0.19%)

06:19
08/19/19
08/19
06:19
08/19/19
06:19
Upgrade
Aramark rating change  »

Aramark upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.95

4.74 (2.38%)

06:19
08/19/19
08/19
06:19
08/19/19
06:19
Downgrade
Amgen rating change  »

Amgen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

POL

PolyOne

$31.01

0.73 (2.41%)

06:18
08/19/19
08/19
06:18
08/19/19
06:18
Hot Stocks
PolyOne to sell PP&S business to SK Capital Partners for $775M in cash »

PolyOne announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CNHI

CNH Industrial

$8.82

0.18 (2.08%)

06:18
08/19/19
08/19
06:18
08/19/19
06:18
Upgrade
CNH Industrial rating change  »

CNH Industrial upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLC

EnLink Midstream

$7.74

0.19 (2.52%)

06:17
08/19/19
08/19
06:17
08/19/19
06:17
Downgrade
EnLink Midstream rating change  »

EnLink Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.